Flexible Bronchoscopy in Resistant Pneumonia in PICU
FFP-RP PICU
Outcome of Flexible Fiber Optic Bronchoscopy Usage in Children With Resistant Pneumonia in Pediatric Intensive Care Units (PICU )
1 other identifier
observational
70
1 country
1
Brief Summary
Pneumonia remains a leading cause of morbidity and mortality among critically ill children admitted to Pediatric Intensive Care Units (PICUs). A proportion of patients fail to demonstrate clinical or radiological improvement despite receiving at least five days of appropriate broad-spectrum antibiotic therapy, a condition commonly referred to as resistant or non-resolving pneumonia. These patients often require further diagnostic evaluation to identify persistent infection, resistant microorganisms, airway abnormalities, or alternative diagnoses. Flexible fiberoptic bronchoscopy (FFB) with bronchoalveolar lavage (BAL) is an important diagnostic procedure that permits direct visualization of the tracheobronchial tree and collection of lower respiratory tract specimens for microbiological analysis. The findings obtained through FFB may identify the underlying etiology of persistent pulmonary disease and guide subsequent therapeutic decisions. This observational study aims to evaluate the diagnostic yield, clinical utility, safety, and impact of flexible fiberoptic bronchoscopy with bronchoalveolar lavage in children with resistant pneumonia admitted to the Pediatric Intensive Care Unit at Abu El-Reesh Children's Hospital, Cairo University. Eligible patients are children who demonstrate persistent clinical and radiological evidence of pneumonia despite receiving at least five days of appropriate first-line broad-spectrum antibiotic therapy. Clinical characteristics, bronchoscopic findings, microbiological results, bronchoalveolar lavage cultures, molecular diagnostic results, treatment modifications, procedure-related complications, and clinical outcomes will be analyzed. The findings of this study are expected to provide evidence regarding the role of flexible bronchoscopy in the diagnostic evaluation and management of resistant pneumonia in critically ill pediatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 3, 2025
CompletedFirst Submitted
Initial submission to the registry
February 12, 2026
CompletedFirst Posted
Study publicly available on registry
February 19, 2026
CompletedJuly 20, 2026
July 1, 2026
2.4 years
February 12, 2026
July 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic yield of flexible fiberoptic bronchoscopy (FFB) in resistant pneumonia
Proportion of patients in whom flexible fiberoptic bronchoscopy with bronchoalveolar lavage identifies a specific etiological pathogen (bacterial, viral, or fungal) responsible for resistant pneumonia
During bronchoscopy and within 72 hours after bronchoscopy where FFB findings were obtained during the procedure and inflammatory markers/chest imaging were reassessed within 72 hours after FFB, with patients followed clinically until PICU discharge
Secondary Outcomes (3)
Clinical improvement after flexible fiberoptic bronchoscopy
72 hours after bronchoscopy
Microbiological diagnostic performance of bronchoalveolar lavage
Within 7 days after bronchoscopy
Clinical outcomes following bronchoscopy
From bronchoscopy until PICU discharge
Study Arms (1)
Children with resistant pneumonia undergoing flexible fiberoptic bronchoscopy
Children admitted to the Pediatric Intensive Care Unit (PICU) with resistant pneumonia who showed no clinical or radiological improvement after at least 5 days of broad-spectrum antibiotic therapy and underwent flexible fiberoptic bronchoscopy with bronchoalveolar lavage as part of their diagnostic evaluation.
Interventions
Flexible fiberoptic bronchoscopy with bronchoalveolar lavage was performed in all enrolled children with resistant pneumonia as part of the diagnostic evaluation. Bronchoscopy was used for direct airway visualization and bronchoalveolar lavage sample collection for microbiological analysis to guide subsequent clinical management.
Eligibility Criteria
Children aged 3 months to 18 years admitted to the Pediatric Intensive Care Unit at Abu El-Reesh Children's Hospital, Cairo University, with resistant pneumonia who underwent flexible fiberoptic bronchoscopy with bronchoalveolar lavage as part of their diagnostic evaluation
You may qualify if:
- \- Children aged more than 3 months and less than 14 years.
- Admitted to Pediatric Intensive Care Unit (PICU).
- Severe pneumonia defined as cough or difficulty breathing with at least one of the following:
- Oxygen saturation \< 90% on pulse oximetry
- Severe respiratory distress
- General danger signs (inability to drink, lethargy, convulsions)
- No clinical or radiological improvement after at least five days of first-line broad-spectrum antibiotic therapy.
- Informed consent obtained from parent or legal guardian.
You may not qualify if:
- Age less than 3 months or more than 14 years.
- Absolute contraindication to flexible bronchoscopy (severe refractory hypoxemia, hemodynamic instability, uncorrected bleeding disorder).
- refusal of informed consent by parents or legal guardian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abu Elreesh children hospital , faculty of medicine , cairo university
Cairo, Cairo Governorate, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assistant lecturer of pediatrics
Study Record Dates
First Submitted
February 12, 2026
First Posted
February 19, 2026
Study Start
February 5, 2023
Primary Completion
June 29, 2025
Study Completion
August 3, 2025
Last Updated
July 20, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly shared because the study contains patient-level clinical data and no formal data-sharing plan has been established.